Catalyst Pharmaceuticals

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$126,424
$122,710
$98,509
$110,568
Gross Profit
107,147
97,961
85,989
85,700
EBITDA
50,909
54,246
36,556
50,835
EBIT
44,742
27,058
41,692
Net Income
43,884
40,794
23,275
34,844
Net Change In Cash
126,424
122,710
98,509
110,568
Free Cash Flow
72,612
64,125
31,726
19,555
Cash
442,331
375,693
310,411
137,636
Basic Shares
125,407
124,655
123,403
113,755

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$398,204
$214,203
$140,833
$119,072
Gross Profit
313,672
179,810
118,949
102,033
EBITDA
86,812
103,077
52,577
42,188
EBIT
53,669
101,838
52,385
41,303
Net Income
71,410
83,079
39,482
74,983
Net Change In Cash
398,204
214,203
140,833
119,072
Cost of Revenue
126,950
41,208
Free Cash Flow
-54,924
116,018
59,351
45,023
Cash
137,636
298,395
171,445
130,237
Basic Shares
113,753
111,375
107,795
106,242

Earnings Calls

Quarter EPS
2024-09-30
$0.35
2024-06-30
$0.33
2024-03-31
$0.19
2023-12-31
$0.31